Ashraf Siddig Yousif Hamad Elneel, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunoglobulin Class Switching | 3 | 2014 | 289 | 0.620 |
Why?
|
Uracil-DNA Glycosidase | 2 | 2014 | 37 | 0.580 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 2 | 2014 | 101 | 0.570 |
Why?
|
Influenza Vaccines | 2 | 2020 | 766 | 0.400 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 119 | 0.330 |
Why?
|
Influenza, Human | 3 | 2020 | 1528 | 0.330 |
Why?
|
Receptors, CCR5 | 1 | 2019 | 488 | 0.280 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2018 | 280 | 0.270 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2019 | 545 | 0.270 |
Why?
|
Influenza A virus | 1 | 2019 | 457 | 0.260 |
Why?
|
Open Reading Frames | 1 | 2019 | 814 | 0.260 |
Why?
|
Complement System Proteins | 1 | 2018 | 782 | 0.250 |
Why?
|
HIV Seropositivity | 1 | 2019 | 955 | 0.220 |
Why?
|
AIDS Vaccines | 1 | 2020 | 895 | 0.220 |
Why?
|
Cytidine Deaminase | 2 | 2014 | 245 | 0.200 |
Why?
|
Schistosoma haematobium | 1 | 2011 | 13 | 0.200 |
Why?
|
Schistosomiasis haematobia | 1 | 2011 | 15 | 0.200 |
Why?
|
HIV-1 | 2 | 2019 | 6849 | 0.200 |
Why?
|
Antibodies, Helminth | 1 | 2011 | 57 | 0.190 |
Why?
|
HIV Antibodies | 1 | 2018 | 1300 | 0.190 |
Why?
|
Immunity, Humoral | 3 | 2020 | 604 | 0.190 |
Why?
|
Schistosomiasis mansoni | 1 | 2011 | 94 | 0.180 |
Why?
|
RNA Interference | 1 | 2019 | 2846 | 0.180 |
Why?
|
Interleukin-6 | 1 | 2020 | 3215 | 0.180 |
Why?
|
Schistosoma mansoni | 1 | 2011 | 156 | 0.180 |
Why?
|
Dendritic Cells | 1 | 2020 | 2725 | 0.170 |
Why?
|
Immunoglobulin Variable Region | 1 | 2020 | 419 | 0.160 |
Why?
|
Enterocytes | 1 | 2020 | 220 | 0.160 |
Why?
|
Antibodies, Neutralizing | 1 | 2018 | 1933 | 0.160 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4291 | 0.160 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 361 | 0.150 |
Why?
|
Antibodies, Viral | 1 | 2019 | 3143 | 0.150 |
Why?
|
Nasal Mucosa | 1 | 2020 | 412 | 0.140 |
Why?
|
Goblet Cells | 1 | 2020 | 299 | 0.140 |
Why?
|
Interferon Type I | 1 | 2020 | 559 | 0.130 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4742 | 0.130 |
Why?
|
DNA Breaks, Single-Stranded | 1 | 2014 | 24 | 0.120 |
Why?
|
Immunoglobulin G | 2 | 2018 | 4541 | 0.120 |
Why?
|
Immunoglobulin Switch Region | 1 | 2014 | 45 | 0.120 |
Why?
|
HIV Infections | 3 | 2020 | 17165 | 0.110 |
Why?
|
Lipopolysaccharides | 1 | 2020 | 2209 | 0.100 |
Why?
|
Catalysis | 1 | 2014 | 775 | 0.100 |
Why?
|
Mice, Transgenic | 3 | 2020 | 9530 | 0.090 |
Why?
|
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2020 | 26 | 0.090 |
Why?
|
Toll-Like Receptor 7 | 1 | 2020 | 177 | 0.080 |
Why?
|
Interferon Regulatory Factors | 1 | 2020 | 260 | 0.080 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 226 | 0.080 |
Why?
|
HIV Antigens | 1 | 2020 | 325 | 0.080 |
Why?
|
Complementarity Determining Regions | 1 | 2019 | 149 | 0.080 |
Why?
|
Antibody Affinity | 1 | 2019 | 245 | 0.080 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2019 | 158 | 0.080 |
Why?
|
Host-Parasite Interactions | 1 | 2019 | 301 | 0.070 |
Why?
|
Plasma Cells | 1 | 2020 | 591 | 0.070 |
Why?
|
Toll-Like Receptor 4 | 1 | 2020 | 580 | 0.070 |
Why?
|
Immunization, Secondary | 1 | 2019 | 368 | 0.070 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2019 | 649 | 0.070 |
Why?
|
Mice | 7 | 2020 | 81208 | 0.070 |
Why?
|
Protein Engineering | 1 | 2019 | 541 | 0.060 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1529 | 0.060 |
Why?
|
Glycosylation | 1 | 2018 | 1096 | 0.060 |
Why?
|
Species Specificity | 1 | 2019 | 2418 | 0.060 |
Why?
|
Animals | 9 | 2020 | 167963 | 0.060 |
Why?
|
Receptors, Fc | 1 | 2018 | 534 | 0.060 |
Why?
|
Antigens, Viral | 1 | 2018 | 980 | 0.060 |
Why?
|
Cell Death | 1 | 2019 | 1672 | 0.060 |
Why?
|
Cell Line | 3 | 2020 | 15620 | 0.060 |
Why?
|
Models, Molecular | 1 | 2014 | 5434 | 0.060 |
Why?
|
Polysaccharides | 1 | 2020 | 1016 | 0.050 |
Why?
|
India | 1 | 2019 | 2336 | 0.050 |
Why?
|
Gene Frequency | 1 | 2019 | 3615 | 0.050 |
Why?
|
Parasite Egg Count | 1 | 2011 | 29 | 0.050 |
Why?
|
Agricultural Workers' Diseases | 1 | 2011 | 28 | 0.050 |
Why?
|
Sudan | 1 | 2011 | 86 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 22023 | 0.050 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1841 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2020 | 3707 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5791 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6216 | 0.040 |
Why?
|
Nanoparticles | 1 | 2019 | 1943 | 0.040 |
Why?
|
Receptors, Virus | 1 | 2020 | 639 | 0.030 |
Why?
|
Feces | 1 | 2011 | 1455 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1021 | 0.030 |
Why?
|
Genotype | 1 | 2019 | 12960 | 0.030 |
Why?
|
Transcription Factors | 1 | 2014 | 12103 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3804 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2020 | 2316 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2020 | 11481 | 0.030 |
Why?
|
Child, Preschool | 2 | 2019 | 42063 | 0.030 |
Why?
|
Child | 3 | 2020 | 79806 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 87810 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2014 | 877 | 0.020 |
Why?
|
Fluorescence | 1 | 2014 | 751 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 858 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4122 | 0.020 |
Why?
|
Inflammation | 1 | 2020 | 10756 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2011 | 5201 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1693 | 0.020 |
Why?
|
Humans | 7 | 2020 | 760621 | 0.020 |
Why?
|
DNA Primers | 1 | 2014 | 2819 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2014 | 1526 | 0.020 |
Why?
|
Young Adult | 2 | 2019 | 58741 | 0.020 |
Why?
|
Mycobacterium tuberculosis | 1 | 2020 | 1903 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2380 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2014 | 2057 | 0.020 |
Why?
|
Signal Transduction | 1 | 2020 | 23376 | 0.020 |
Why?
|
Tuberculosis | 1 | 2020 | 2001 | 0.020 |
Why?
|
Prevalence | 1 | 2011 | 15687 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2020 | 18957 | 0.010 |
Why?
|
DNA Damage | 1 | 2014 | 2442 | 0.010 |
Why?
|
Female | 3 | 2019 | 391270 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 5870 | 0.010 |
Why?
|
Chromatin | 1 | 2014 | 2938 | 0.010 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.010 |
Why?
|
Lung | 1 | 2020 | 9994 | 0.010 |
Why?
|
Middle Aged | 2 | 2019 | 220352 | 0.010 |
Why?
|
Adult | 2 | 2019 | 219994 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 25942 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8624 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14372 | 0.010 |
Why?
|
Male | 2 | 2019 | 359744 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2011 | 58995 | 0.010 |
Why?
|
Aged | 1 | 2011 | 169152 | 0.000 |
Why?
|